|
TNPO2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.210370E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.019900E-04 |
| Normal-vs-Stage2 |
8.959200E-01 |
| Normal-vs-Stage3 |
3.590000E-01 |
| Normal-vs-Stage4 |
8.521400E-01 |
| Stage1-vs-Stage2 |
2.986000E-02 |
| Stage1-vs-Stage3 |
2.19349999999174E-05 |
| Stage1-vs-Stage4 |
3.815900E-03 |
| Stage2-vs-Stage3 |
4.136200E-01 |
| Stage2-vs-Stage4 |
7.959200E-01 |
| Stage3-vs-Stage4 |
5.737400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.404600E-01 |
| Normal-vs-AfricanAmerican |
5.211600E-02 |
| Normal-vs-Asian |
8.696900E-03 |
| Caucasian-vs-AfricanAmerican |
1.538960E-01 |
| Caucasian-vs-Asian |
1.102450E-01 |
| AfricanAmerican-vs-Asian |
3.323600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.572600E-01 |
| Normal-vs-Female |
2.363400E-03 |
| Male-vs-Female |
1.942540E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.159390E-01 |
| Normal-vs-Age(41-60Yrs) |
1.627970E-02 |
| Normal-vs-Age(61-80Yrs) |
7.160200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.550800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.524600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.529760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.570560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.137700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.547970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.739000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.417470E-03 |
| Normal-vs-Grade 2 |
7.621700E-03 |
| Normal-vs-Grade 3 |
8.584200E-01 |
| Normal-vs-Grade 4 |
3.558400E-01 |
| Grade 1-vs-Grade 2 |
6.855200E-03 |
| Grade 1-vs-Grade 3 |
4.31440000000505E-05 |
| Grade 1-vs-Grade 4 |
2.0503000000005E-05 |
| Grade 2-vs-Grade 3 |
4.596300E-03 |
| Grade 2-vs-Grade 4 |
2.604000E-03 |
| Grade 3-vs-Grade 4 |
2.541400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.442000E-03 |
| Normal-vs-ccB subtype |
6.145200E-01 |
| ccA subtype-vs-ccB subtype |
3.172000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.253400E-01 |
| Normal-vs-N1 |
3.509400E-01 |
| N0-vs-N1 |
5.702400E-01 |
|
|
